What tests and values indicate pre-eclampsia in a suspected patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Testing for Pre-eclampsia

When pre-eclampsia is suspected, immediately measure blood pressure and perform urine dipstick testing for proteinuria, followed by comprehensive laboratory evaluation including complete blood count, liver transaminases, serum creatinine, and quantification of proteinuria if dipstick is positive. 1

Essential Diagnostic Tests

Blood Pressure Measurement

  • Measure blood pressure with properly calibrated equipment using appropriate cuff size (large cuff if mid-upper arm circumference >33 cm) 1
  • Confirm systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg on two separate occasions at least 15 minutes apart 1
  • For severe hypertension (≥160/110 mmHg), confirmation is required within 15 minutes 1

Proteinuria Assessment

  • Start with urine dipstick testing at every assessment after 20 weeks of gestation 2
  • If dipstick shows ≥1+ (≥30 mg/dL), proceed immediately to quantification 3
  • Quantification methods:
    • Spot urine protein-to-creatinine ratio (PCR) ≥30 mg/mmol (or ≥0.3 mg/mg) is the preferred rapid method 1, 3
    • 24-hour urine collection showing ≥300 mg protein is the traditional gold standard but time-consuming 2, 3

Comprehensive Laboratory Panel

Obtain at minimum twice weekly (more frequently if clinical deterioration): 1, 4

  • Complete blood count with platelet count
  • Liver transaminases (ALT/AST)
  • Serum creatinine
  • Uric acid (optional but helpful)

Diagnostic Values Indicating Pre-eclampsia

Core Diagnostic Criteria

Pre-eclampsia is diagnosed when new-onset hypertension (≥140/90 mmHg) after 20 weeks occurs with ANY ONE of the following: 1, 3

Proteinuria (if present):

  • Spot urine PCR ≥30 mg/mmol (≥0.3 mg/mg) 1, 3
  • 24-hour urine protein ≥300 mg 2, 3
  • Dipstick ≥1+ (requires quantification for confirmation) 2, 3

Maternal Organ Dysfunction (even WITHOUT proteinuria):

  • Thrombocytopenia: Platelet count <100,000/μL 1, 5
  • Liver involvement: Transaminases >2× upper limit of normal 1, 5
  • Renal insufficiency: Serum creatinine ≥1.1 mg/dL or doubling of baseline 1
  • Neurological symptoms: Persistent severe headache unresponsive to medication or visual disturbances 1
  • Pulmonary edema: Maternal pulse oximetry <90% 1

Uteroplacental Dysfunction:

  • Fetal growth restriction on ultrasound 3
  • Abnormal umbilical artery Doppler 6

Critical Diagnostic Pitfalls to Avoid

Proteinuria Is NOT Required

Approximately 25% of pre-eclampsia cases lack proteinuria 1, 3—never dismiss the diagnosis based on negative proteinuria if hypertension is present with other organ dysfunction 3. Women can develop life-threatening HELLP syndrome without any proteinuria 3, 4.

Symptoms Without Severe Hypertension

Do not dismiss symptoms in the absence of severe blood pressure elevation: 34% of eclamptic women had maximum diastolic BP ≤100 mmHg 2, 1. Headache is an independent risk factor for eclampsia, and epigastric pain predicts serious morbidity even without severe hypertension 2, 1.

Dipstick Limitations

A positive dipstick result alone is prone to false positives from reader error and concentration errors 2. Always quantify with PCR or 24-hour collection 2, 3. However, dipstick ≥1+ with new hypertension should be treated as pre-eclampsia until proven otherwise 2.

Fetal Compromise as First Sign

Fetal compromise (reduced fetal movements, small for gestational age) can be the first clinical indication of pre-eclampsia 2 and should always trigger immediate assessment of blood pressure and proteinuria 2.

Severity Assessment Values

Severe Features Requiring Immediate Action:

  • Severe hypertension: BP ≥160/110 mmHg 1, 5
  • Thrombocytopenia <100,000/μL 1, 5
  • Liver transaminases >2× normal, especially with right upper quadrant or epigastric pain 1, 5
  • Serum creatinine ≥1.1 mg/dL 1
  • Persistent severe headache 1
  • Visual disturbances (scotomata, cortical blindness) 1
  • Pulmonary edema 1
  • Eclampsia (seizures) 1

Practical Testing Algorithm

  1. Immediate assessment when pre-eclampsia suspected:

    • Blood pressure measurement (confirm elevation) 1
    • Urine dipstick for proteinuria 2
  2. If dipstick negative for proteinuria:

    • Obtain laboratory investigations to exclude pre-eclampsia: CBC, liver enzymes, creatinine 3
    • Evaluate fetal well-being with ultrasound 3
  3. If dipstick ≥1+ or any concerning symptoms:

    • Quantify proteinuria with spot PCR (preferred) or 24-hour collection 2, 3
    • Complete laboratory panel: CBC with platelets, liver transaminases, creatinine 1, 4
    • Fetal assessment with ultrasound for growth and Doppler 4
  4. Ongoing monitoring if pre-eclampsia confirmed:

    • Laboratory tests at least twice weekly (more frequently if deterioration) 1, 4
    • Blood pressure monitoring every 4 hours or more frequently if severe features 1

References

Guideline

Diagnosis and Management of Preeclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Proteinuria Threshold for Pre-eclampsia Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Severe Preeclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Preeclampsia: an update.

Acta anaesthesiologica Belgica, 2014

Research

The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.